Main Article

Most labs with R&D interests are just on the cusp of exploring how to leverage their intellectual property (IP) assets for financial gain. But as both House and Senate versions of the Patent Reform Act continue to be debated in Congress, it’s important that labs understand the evolving legal complexities of IP protection, including avoiding costly patent infringement litigation, warned legal experts at Washington G-2 Reports’ Lab Law, Compliance & Liability Summit, held December 5-7 in Ft. Lauderdale, Florida.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

January 2008 - Table of Contents

LIR January 2008 (full PDF issue)

Competitive Demo Bids Due Feb. 15: CMS Confirms List of Excluded Cities

Quest, LabCorp, Sonic Land Humana Contract Extensions

‘First to File’ Patent Reform Efforts Underscore Labs’ Need to Protect IP

Goldman Sachs Identifies Current Challenges, Future Growth for Quest and LabCorp

Outlook for the Lab Industry: Five Execs’ Predictions for 2008

India’s Lal PathLabs Intent on Outsourcing United States Testing

Lab Stocks up 17% in ’07, Two New Companies Added for 2008

Caris Diagnostics to Acquire Molecular Profiling Institute